Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine
- 11 October 2019
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Mmwr. Morbidity and Mortality Weekly Report
- Vol. 68 (40), 880-884
- https://doi.org/10.15585/mmwr.mm6840a3
Abstract
During May 19–September 28, 2019, low levels of influenza activity were reported in the United States.Keywords
This publication has 9 references indexed in Scilit:
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza SeasonMMWR. Recommendations and Reports, 2019
- Intense interseasonal influenza outbreaks, Australia, 2018/19Eurosurveillance, 2019
- Oseltamivir Effect on Antibiotic-Treated Lower Respiratory Tract Complications in Virologically Positive Randomized Trial ParticipantsClinical Infectious Diseases, 2013
- Oseltamivir and Risk of Lower Respiratory Tract Complications in Patients With Flu Symptoms: A Meta-analysis of Eleven Randomized Clinical TrialsClinical Infectious Diseases, 2011
- Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).2011
- Early Oseltamivir Treatment of Influenza in Children 1–3 Years of Age: A Randomized Controlled TrialClinical Infectious Diseases, 2010
- Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trialThe Pediatric Infectious Disease Journal, 2000
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000